Compare M&T Bank Corporation (MTB) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while Regeneron Pharmaceuticals Inc trades at $673.67 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and M&T Bank Corporation pays the higher dividend (2.41%). Which is the better fit depends on your goals.
| MTB | REGN | |
|---|---|---|
Market Cap | $36.15B | $70.47B |
Sector | Financials | Health |
52-Week High | $254.04 | $812.27 |
52-Week Low | $178.63 | $545.46 |
Dividend Yield | 2.41% | 0.56% |
Enterprise Value | — | $64.42B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
